Geron Price to Book Ratio 2006-2021 | GERN

Historical price to book ratio values for Geron (GERN) over the last 10 years. The current price to book ratio for Geron as of October 22, 2021 is 2.62.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Geron Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2021-10-22 1.45 2.64
2021-06-30 1.41 $0.55 2.57
2021-03-31 1.58 $0.63 2.50
2020-12-31 1.59 $0.68 2.34
2020-09-30 1.74 $0.75 2.32
2020-06-30 2.18 $0.81 2.70
2020-03-31 1.19 $0.60 1.97
2019-12-31 1.36 $0.68 2.01
2019-09-30 1.33 $0.79 1.68
2019-06-30 1.41 $0.84 1.68
2019-03-31 1.66 $0.91 1.83
2018-12-31 1.00 $0.95 1.05
2018-09-30 1.76 $0.98 1.79
2018-06-30 3.43 $0.97 3.53
2018-03-31 4.25 $0.58 7.27
2017-12-31 1.80 $0.65 2.77
2017-09-30 2.18 $0.68 3.21
2017-06-30 2.77 $0.71 3.90
2017-03-31 2.27 $0.74 3.08
2016-12-31 2.07 $0.77 2.69
2016-09-30 2.26 $0.81 2.79
2016-06-30 2.68 $0.82 3.27
2016-03-31 2.92 $0.86 3.40
2015-12-31 4.84 $0.90 5.41
2015-09-30 2.77 $0.93 2.96
2015-06-30 4.28 $0.75 5.72
2015-03-31 3.77 $0.79 4.76
2014-12-31 3.25 $0.83 3.91
2014-09-30 2.00 $0.87 2.29
2014-06-30 3.04 $0.92 3.30
2014-03-31 1.98 $0.96 2.06
2013-12-31 4.49 $0.46 9.82
2013-09-30 3.17 $0.48 6.61
2013-06-30 1.42 $0.53 2.67
2013-03-31 1.01 $0.58 1.74
2012-12-31 1.34 $0.66 2.03
2012-09-30 1.62 $0.76 2.12
2012-06-30 1.62 $0.87 1.86
2012-03-31 1.61 $0.99 1.62
2011-12-31 1.40 $1.12 1.26
2011-09-30 2.01 $1.33 1.51
2011-06-30 3.80 $1.45 2.61
2011-03-31 4.78 $1.61 2.97
2010-12-31 4.91 $1.57 3.13
2010-09-30 5.24 $1.51 3.47
2010-06-30 4.76 $1.61 2.95
2010-03-31 5.38 $1.77 3.04
2009-12-31 5.26 $1.87 2.82
2009-09-30 6.21 $2.00 3.11
2009-06-30 7.27 $2.08 3.49
2009-03-31 4.23 $2.29 1.85
2008-12-31 4.42 $2.08 2.13
2008-09-30 3.74 $2.26 1.65
2008-06-30 3.27 $2.44 1.34
2008-03-31 4.62 $2.59 1.79
2007-12-31 5.38 $2.70 1.99
2007-09-30 6.93 $2.72 2.55
2007-06-30 6.67 $2.83 2.36
2007-03-31 6.63 $2.99 2.22
2006-12-31 8.32 $2.47 3.37
2006-09-30 5.94 $2.65 2.24
2006-06-30 6.54 $2.79 2.35
2006-03-31 7.87 $2.83 2.78
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.465B $0.000B
Geron Corporation is a scientific research company that is developing techniques for the health services industry. Their research is currently divided in three different areas. First, they are looking into telomeres and telomerase and their roles in cellular aging and cancer. Second, they are looking pluripotent stem cells as a potential source for the manufacturing of replacement cells and tissues. Lastly, the company is researching nuclear transfer as a potential mechanism for generating genetically matched cells and tissues.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $127.994B 8.52
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.309B 20.85
Biohaven Pharmaceutical Holding (BHVN) United States $9.150B 0.00
Emergent Biosolutions (EBS) United States $2.677B 6.46
Arcus Biosciences (RCUS) United States $2.522B 0.00
Myovant Sciences (MYOV) United Kingdom $1.905B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.799B 0.00
Zymeworks (ZYME) Canada $1.071B 0.00
Ambrx Biopharma (AMAM) United States $0.474B 0.00
SQZ Biotechnologies (SQZ) United States $0.341B 0.00
Enzo Biochem (ENZ) United States $0.160B 15.76